Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
about
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cellsGingival Mesenchymal Stem/Progenitor Cells: A Unique Tissue Engineering GemTreg cells: a potential regulator for IL-22 expression?Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionMechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infectionsCellular and molecular determinants for the development of natural and induced regulatory T cellsFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsFas-Fas Ligand: Checkpoint of T Cell Functions in Multiple SclerosisProgress and prospect of mesenchymal stem cell-based therapy in atherosclerosisTolerance in liver transplantation: Biomarkers and clinical relevanceTGF-beta: a mobile purveyor of immune privilegeT cell-mediated host immune defenses in the lungExtrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflictRetinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cellsDifferentiation of effector CD4 T cell populations (*)Regulatory T cells: mechanisms of differentiation and functionImmunological parameters as a new lead in the diagnosis of ovarian cancer.Induction of auto-reactive regulatory T cells by stimulation with immature autologous dendritic cells.Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Placental immunopathology in the FIV-infected cat: a role for inflammation in compromised pregnancy?B cells inhibit the antitumor immunity against an established murine fibrosarcomaTherapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases.Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ TregRegulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune HomeostasisInduced Regulatory T Cells Superimpose Their Suppressive Capacity with Effector T Cells in Lymph Nodes via Antigen-Specific S1p1-Dependent Egress Blockage.Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acidVasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels.Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinomaA peripheral circulating compartment of natural naive CD4 TregsMechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis BTransforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development.Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes.IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytesValproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase.Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot.Decreased percentage of CD4(+)Foxp3(+)TGF-β(+) and increased percentage of CD4(+)IL-17(+) cells in bronchoalveolar lavage of asthmaticsRegulatory T-cell stability and plasticity in mucosal and systemic immune systems.Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanomaRegulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner.
P2860
Q24681974-05635130-43EC-4E20-876E-545883439FDAQ26745515-6A179D15-6E79-44A4-9302-37C19EBF5049Q26824855-9C7221C7-A2BF-45BE-9FE1-1C329FB44CD0Q26850218-0F41D342-6BC1-4539-BD1B-C0D59E152C32Q26850457-5AB05C7C-CF95-4AE2-A1F8-F9B183A3D74EQ26853475-A4784040-E62B-4B7C-B2EB-CE0CC0B53193Q26865532-2B7E3F99-C75E-4959-91B9-9FCE6A5E87E3Q28074658-39954CE4-8B0C-4878-BB82-AA74FD2F3DAFQ28075184-980EEB3F-BF13-4192-BC9A-9280E16D8473Q28079523-13E4B91F-D7B6-473D-9E20-3E13FCDC6E66Q28263622-443421B5-11CC-4696-9C43-BA19ABD8F640Q28395374-6B4B91CF-045B-4EE7-997A-0B4CCFC38CCCQ28728365-EF6FDDF1-AC09-4029-A116-E3863E90FA42Q28743652-B7ADC004-73A3-40DA-A3FD-707115A1F85EQ29614838-7842CBDE-59DB-4C8B-ACE9-3F6232D06351Q29620731-90FF7AAE-790E-402A-999D-936F84733C4DQ30414037-3539518F-BD23-4307-8E47-47DDA9319EF5Q33278993-331E19A4-F9D6-4F8A-93C3-374B7833008EQ33403052-A5585DD8-D88D-401A-B913-EF65F0B1B4D9Q33587443-A83238E5-F06D-4D96-9B1B-DCA32E28FD9FQ33653289-CBDFF1EC-E9AF-4FE2-9B0C-0341AB0157BAQ33684762-F4F2F1D2-EB8A-4ED7-A8F6-32B100D77789Q33684806-761B0D7B-501C-4362-B1B4-D89B82D733ADQ33722444-BE152ACD-58AD-42A7-AC91-EB48599FA9E1Q33729446-1B575A54-0A37-408F-ABDF-442D673ECE5FQ33770196-ECBBCCFB-D906-44FB-8A5C-EA94D40639F9Q33778359-CD064175-E39B-4861-B359-45E28F681F61Q33826520-F4F0B047-6E41-4141-9997-3114160CADFAQ33834337-92E11B1B-F698-4ADC-8209-D20C58FF7D64Q33865874-E104B194-5A67-436C-B066-CDF3BEF4CD90Q33867509-126FE208-0CE0-41E4-886B-B63E92421D59Q33892077-8963163B-9503-4A16-972E-E21729049A4AQ33900940-6DB789DF-33BF-4560-98A7-7DE7C00DB561Q33920273-57A87B0C-544E-415A-B48F-26BFBC24E33AQ33966855-2FB19E62-EE8C-4CE6-8EC6-A34C6A4EBAB1Q33999367-8514CC5D-B817-4BDD-AA75-41F702C9127BQ34049727-2F0DDFC0-61D3-426F-A493-D490CFA482E3Q34075568-C3BA1290-B863-41A8-AB43-D2527F6E820DQ34111789-2965EC1B-EE8B-41A3-A966-60481EF7D696Q34125717-03D9DC60-A0B0-4667-A41D-C3763C29C380
P2860
Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Natural and induced CD4+CD25+ ...... of IL-2, TGF-beta, and IL-10.
@en
Natural and induced CD4+CD25+ ...... of IL-2, TGF-beta, and IL-10.
@nl
type
label
Natural and induced CD4+CD25+ ...... of IL-2, TGF-beta, and IL-10.
@en
Natural and induced CD4+CD25+ ...... of IL-2, TGF-beta, and IL-10.
@nl
prefLabel
Natural and induced CD4+CD25+ ...... of IL-2, TGF-beta, and IL-10.
@en
Natural and induced CD4+CD25+ ...... of IL-2, TGF-beta, and IL-10.
@nl
P2093
P1476
Natural and induced CD4+CD25+ ...... of IL-2, TGF-beta, and IL-10.
@en
P2093
David A Horwitz
Harold Soucier
J Dixon Gray
Ju Hua Wang
Song Guo Zheng
P304
P356
10.4049/JIMMUNOL.172.9.5213
P407
P577
2004-05-01T00:00:00Z